Your browser doesn't support javascript.
loading
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort.
Schmid, Sabine; Mauti, Laetitia A; Friedlaender, Alex; Blum, Veronika; Rothschild, Sacha I; Bouchaab, Hasna; Frösch, Patrizia; Britschgi, Christian; König, David; Wannesson, Luciano; Janthur, Wolf-Dieter; Schär, Sämi; Demmer, Izadora; Addeo, Alfredo; Jochum, Wolfram; Früh, Martin.
Afiliación
  • Schmid S; Department of Oncology and Haematology, Cantonal Hospital St. Gallen, 9007, St. Gallen, Switzerland. sabine.schmid@kssg.ch.
  • Mauti LA; Lung Unit, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. sabine.schmid@kssg.ch.
  • Friedlaender A; Department of Oncology and Haematology, Cantonal Hospital St. Gallen, 9007, St. Gallen, Switzerland.
  • Blum V; Oncologie, Hôpitaux universitaires de Genève, Geneva, Switzerland.
  • Rothschild SI; Department of Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Bouchaab H; Department of Oncology, University Hospital Basel, Basel, Switzerland.
  • Frösch P; Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Britschgi C; Istituto Oncologico della Svizzera Italiana, Ospedale Regionale di Bellinzona e Valli, Bellinzona, Switzerland.
  • König D; Department of Medical Oncology and Hematology, University Hospital Zurich, Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
  • Wannesson L; Department of Oncology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
  • Janthur WD; Istituto Oncologico della Svizzera Italiana, Ospedale Regionale di Bellinzona e Valli, Bellinzona, Switzerland.
  • Schär S; Department of Oncology, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Demmer I; SAKK, Swiss Group for Clinical Cancer Research, Coordinating Center, Bern, Switzerland.
  • Addeo A; Institute of Pathology, Cantonal Hospital St. Gallen, 9007, St. Gallen, Switzerland.
  • Jochum W; Oncologie, Hôpitaux universitaires de Genève, Geneva, Switzerland.
  • Früh M; Institute of Pathology, Cantonal Hospital St. Gallen, 9007, St. Gallen, Switzerland.
Cancer Immunol Immunother ; 69(8): 1605-1613, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32307579

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células Pequeñas / Inmunoterapia / Neoplasias Pulmonares / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células Pequeñas / Inmunoterapia / Neoplasias Pulmonares / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Suiza